Ian Coldicott

575 total citations
13 papers, 268 citations indexed

About

Ian Coldicott is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ian Coldicott has authored 13 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ian Coldicott's work include Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ian Coldicott is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ian Coldicott collaborates with scholars based in United Kingdom, United States and Italy. Ian Coldicott's co-authors include Mimoun Azzouz, Katherine E. Lewis, Pamela J. Shaw, Andrew J. Grierson, Vera Lukashchuk, Monika A. Myszczynska, Evangelia Karyka, Laura Ferraiuolo, Paul R. Heath and Adrian Higginbottom and has published in prestigious journals such as Brain, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Ian Coldicott

11 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Coldicott United Kingdom 10 138 124 103 47 44 13 268
Anna Szuto Canada 10 219 1.6× 160 1.3× 110 1.1× 58 1.2× 57 1.3× 20 361
Mehri Moradi Germany 10 250 1.8× 86 0.7× 137 1.3× 86 1.8× 14 0.3× 14 358
Jonathan R. Brent United States 6 181 1.3× 174 1.4× 112 1.1× 87 1.9× 21 0.5× 9 333
Keith Crosby United States 8 160 1.2× 104 0.8× 51 0.5× 75 1.6× 72 1.6× 10 292
Femke van Diggelen Denmark 5 171 1.2× 184 1.5× 136 1.3× 35 0.7× 13 0.3× 5 269
Katherine E. Lewis Australia 9 140 1.0× 177 1.4× 113 1.1× 50 1.1× 32 0.7× 11 302
Maximilian Naujock Germany 10 154 1.1× 120 1.0× 58 0.6× 96 2.0× 27 0.6× 14 290
Francesca Mattedi United Kingdom 6 184 1.3× 40 0.3× 67 0.7× 40 0.9× 15 0.3× 12 229
Zachary T. McEachin United States 10 210 1.5× 94 0.8× 48 0.5× 58 1.2× 58 1.3× 18 354
Lauren M. Gittings United States 9 299 2.2× 184 1.5× 120 1.2× 54 1.1× 20 0.5× 11 404

Countries citing papers authored by Ian Coldicott

Since Specialization
Citations

This map shows the geographic impact of Ian Coldicott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Coldicott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Coldicott more than expected).

Fields of papers citing papers by Ian Coldicott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Coldicott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Coldicott. The network helps show where Ian Coldicott may publish in the future.

Co-authorship network of co-authors of Ian Coldicott

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Coldicott. A scholar is included among the top collaborators of Ian Coldicott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Coldicott. Ian Coldicott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Badger, Shirlene, Ian Coldicott, Adrian Higginbottom, et al.. (2025). A bacterial artificial chromosome mouse model of amyotrophic lateral sclerosis manifests ‘space cadet syndrome’ on two FVB backgrounds. Disease Models & Mechanisms. 18(2).
2.
Webster, Christopher P, Bradley Hall, Ya-Hui Lin, et al.. (2024). RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD. Life Science Alliance. 8(2). e202402757–e202402757.
3.
Bauer, Claudia S., Francesca Sironi, Matthew R. Livesey, et al.. (2022). An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD. Acta Neuropathologica. 144(3). 437–464. 18 indexed citations
4.
Marchi, Paolo, et al.. (2022). Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalization. Brain Communications. 5(1). fcac335–fcac335. 9 indexed citations
5.
Alix, James J. P., Ian Coldicott, Catherine Kendall, et al.. (2022). Fiber optic Raman spectroscopy for the evaluation of disease state in Duchenne muscular dystrophy: An assessment using the mdx model and human muscle. Muscle & Nerve. 66(3). 362–369. 6 indexed citations
6.
Marrone, Lara, Paolo Marchi, Christopher P Webster, et al.. (2022). SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction. Human Molecular Genetics. 31(16). 2693–2710. 10 indexed citations
7.
Lloyd, Gavin R., Catherine Kendall, Ian Coldicott, et al.. (2021). In Vivo Fiber Optic Raman Spectroscopy of Muscle in Preclinical Models of Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy. ACS Chemical Neuroscience. 12(10). 1768–1776. 17 indexed citations
8.
Allen, Scott P., Laura Francis, Allan C. Shaw, et al.. (2019). C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain. 142(12). 3771–3790. 62 indexed citations
9.
Iannitti, Tommaso, Shibi Likhite, Ian Coldicott, et al.. (2018). Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS. Molecular Therapy — Nucleic Acids. 12. 75–88. 35 indexed citations
10.
Alrafiah, Aziza, Evangelia Karyka, Ian Coldicott, et al.. (2018). Plastin 3 Promotes Motor Neuron Axonal Growth and Extends Survival in a Mouse Model of Spinal Muscular Atrophy. Molecular Therapy — Methods & Clinical Development. 9. 81–89. 27 indexed citations
11.
Chandran, Jayanth, Paul Sharp, Evangelia Karyka, et al.. (2017). Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome. Scientific Reports. 7(1). 14766–14766. 15 indexed citations
12.
Herranz-Martín, Saúl, Jayanth Chandran, Katherine E. Lewis, et al.. (2017). Viral delivery of C9ORF72 hexanucleotide repeat expansions in mice lead to repeat length dependent neuropathology and behavioral deficits.. Disease Models & Mechanisms. 10(7). 859–868. 28 indexed citations
13.
Lukashchuk, Vera, Katherine E. Lewis, Ian Coldicott, Andrew J. Grierson, & Mimoun Azzouz. (2016). AAV9-mediated central nervous system–targeted gene delivery via cisterna magna route in mice. Molecular Therapy — Methods & Clinical Development. 3. 15055–15055. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026